Načítá se...
Cardiovascular Effects of Incretin-Based Therapies
GLP-1-modulating therapies are a class of anti-diabetic drugs that improve glycemic control by stimulating glucose-dependent insulin secretion from pancreatic beta-cells. In addition, GLP-1-based therapies have a variety of extrapancreatic effects, including satiety induction and gastric mobility re...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SBDR - Society for Biomedical Diabetes Research
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3280672/ https://ncbi.nlm.nih.gov/pubmed/22262075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2011.8.382 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|